N-terminally modified GLP-1(7-36)amide is resistant to dipeptidyl peptidase-IV degradation whilst maintaining insulinotropic action.

Brian Green, F.P.M. O'Harte, B. Greer, Patrick Harriott, P.R. Flatt

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)154A
JournalProceedings of the Nutrition Society
Volume60
Publication statusPublished - 2001

Cite this